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Aim: Preliminary evidence suggests that inflammation plays a role in the development and prognosis of pulmonary embolism (PE). We
used the neutrophil/lymphocyte ratio (NLR) as a measure of systemic inflammation and investigated its association with PE.
Materials and methods: A total of 266 patients who were diagnosed with PE and a control group of 124 age- and sex-matched healthy
subjects were included in this study. We further classified the PE patients into 2 groups: those who survived and those who died in the
first 30 days. Baseline NLR was measured by dividing neutrophil count to lymphocyte count and was compared between the groups.
Results: Median NLR was significantly higher among patients with PE compared to the healthy control group (3.9 (interquartile range
(IQR): 5.0) vs. 1.9 (IQR: 0.6), P < 0.001). Of the 266 patients with PE, 16 (6%) died within 1 month. Median NLR was significantly higher
among PE patients who died compared to those who survived, as well (3.7 (IQR: 4.3) vs. 9.0 (IQR: 7.9), P < 0.001). The optimal cut-off
values, sensitivities, and specificities of NLR for predicting PE and in-hospital mortality of PE were >2.565 and >5.465, 70.3% and 75.0%,
and 92.7% and 67.6%, respectively. Multiple logistic regression analysis showed that NLR values of >5.465 could define those patients
with a mortal clinical course independently (odds ratio: 13.446, 95% confidence interval: 3.141–57.566, P < 0.001).
Conclusion: A higher NLR, as an emerging marker of inflammation, may be beneficial in determining prognosis in PE patients.
Key words: Neutrophil/lymphocyte ratio, pulmonary embolism, inflammation

1. Introduction
Pulmonary embolism (PE) is well known as an important
disease with high rates of morbidity and mortality. An
approximate annual incidence of 60–70 cases per 100,000
people has been reported, and it is the most common cause
of sudden deaths in hospitals (1).
Systemic inflammation can be measured using a
variety of biochemical and hematological markers. Since
the physiological response to stress of the leukocytes
in circulation leads to an increase in the number of
neutrophils and a decrease in the number of lymphocytes,
the ratio of these subgroups to each other is used as a
marker of inflammation. During inflammatory response,
changes occur in the ratios of leukocyte subgroups in
the circulation. Neutrophilia is accompanied by relative
lymphopenia (2). Therefore, the blood neutrophil/
lymphocyte ratio (NLR) could be an important measure
of systemic inflammation as it is cost-effective, is readily
available, and can be calculated easily. Recently, the NLR,
an emerging marker of inflammation, has been a “hot
topic” as a useful marker of cardiovascular disease as well
* Correspondence: acildrumut@yahoo.com
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as an independent predictor of cardiac or cancer-related
mortality (3).
PE is known to be associated with a leukocyte influx
that occurs early after a thromboembolic event (1 day).
Thrombus development is associated with pulmonary
arterial and deep venous wall inflammation, marked by
an early extravasation of leukocytes and an elevation in
proinflammatory mediators and selectins, indicating a
robust immune response following PE (4–7). As far as we
know, there is no study in the literature on the role of NLR
– which is part of routine blood analysis, can be obtained
easily with the whole blood count, and is quite easy to
calculate – in the determination of the prognosis of PE.
We investigated the prognostic value of NLR in patients
with PE.
2. Materials and methods
2.1. Design
From January 2011 to June 2012, 368 consecutive patients
with PE, as confirmed by spiral computerized tomography
(CT), who were admitted to Dışkapı Yıldırım Beyazıt
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Training and Research Hospital (a tertiary care hospital)
were included in this retrospective study. The local ethics
committee approved the study protocol.
2.2. Study population
A total of 266 patients with a definitive diagnosis of
PE were included in the study and their clinical and
laboratory data were compared with those of a total of
124 healthy adults who were attending their annual checkup as a control group. There were 102 patients who were
prediagnosed with PE but whose diagnosis was not proven
by spiral CT; they were excluded. In addition, patients
with clinical evidence of cancer, acute coronary syndrome,
congestive heart failure, chronic obstructive lung disease,
chronic inflammatory disease, or any systemic infection
that occurred during the first 48 h after admission were
excluded. Patients whose hospital records were incomplete,
who were under the age of 18, or who were diagnosed
with PE using methods other than spiral CT were also
excluded. We classified the PE patients into 2 groups: those
who survived 30 days after PE and those who died in the
first 30 days.
2.3. Laboratory and radiologic analyses
Multislice spiral CT examinations were carried out in the
radiology clinic, using PE protocol (field of view: 35 cm,
section thickness: 3 mm, pitch: 2, and intravenous 120 mL
contrast material), and pulmonary arteries, their branches,
and lung parenchyma were evaluated in detail. Ventilationperfusion scintigraphy was not used for diagnosis because
it is impractical in an emergency department.
In this study, only the first parameters obtained within
30 min of admission were considered. Whole blood count,
white blood cell (WBC) count, neutrophil, lymphocyte,
NLR, D-dimer, troponin-I, and arterial blood gas (pO2,
pCO2, pH) values were recorded. D-dimer values of
>500 µg/L and troponin-I values of >0.06 ng/mL were
considered positive.

2.4. Statistical analyses
Whether the distributions of continuous variables
were normal or not was determined by a Kolmogorov–
Smirnov test. Continuous variables were shown as mean
± standard deviation or median interquartile ranges
(IQR) as applicable. The mean differences between
groups were compared by Student’s t test; otherwise, the
Mann–Whitney U test was applied for comparisons of the
median values. Nominal data were analyzed by Pearson’s
chi-square test. The optimal cut-off points of the NLR to
determine both PE and prognosis were evaluated by a
receiver operating characteristic (ROC) analysis as giving
the maximum sum of sensitivity and specificity for the
significant test. Whether the predictivity of NLR on both
PE and prognosis was statistically significant or not was
evaluated by multiple logistic regression analyses after
adjustment for all possible confounding factors. Odds
ratios (ORs) and 95% confidence intervals (CIs) for each
independent variable were also calculated. A P-value of
less than 0.05 was considered statistically significant. Data
analysis was performed using SPSS 11.5 for Windows
(SPSS Inc., Chicago, IL, USA).
3. Results
The mean age and the female/male ratio of the patients
with PE and the control group were 64.8 ± 14.3 years
(min: 18, max: 86) and 1.23 and 66.1 ± 9.6 years (min:
37, max: 82) and 1.07, respectively. Patients with PE and
the control group were similar in respect to age and sex
(Table 1). Compared to the control group, NLR values of
patients with PE were statistically higher (R = 3.080; 95%
CI: 2.227–4.260; P < 0.001) (Table 1).
Of the 266 patients with PE, 16 (6%) died within 1
month of diagnosis. According to the ROC curve analysis,
the optimal cut-off value of NLR to predict PE was >2.565
with 70.3% sensitivity and 92.7% specificity (area under
the curve (AUC) = 0.817, 95% CI: 0.776–0.859; Table 2).

Table 1. Demographical and clinical characteristics regarding case and control groups. OR: odds ratio, CI: confidence interval.
Variables

Controls

Cases

P-value

OR (95% CI)

Age, years

66.1 ± 9.6

64.8 ± 14.3

0.299

0.992 (0.976–1.009)

Male, n (%)

60 (48.4%)

119 (44.7%)

-

1.000

Female, n (%)

64 (51.6%)

147 (55.3%)

0.501

1.158 (0.755–1.775)

Neutrophils (%)

59.9

61.5

0.253

0.536 (0.480–0.591)

Lymphocytes (%)

31.3

15.6

<0.001

0.132 (0.097–0.162)

NLR

1.9

3.9

<0.001

3.080 (2.227–4.260)

Sex
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Table 2. The results of ROC analysis for NLR determination of disease and mortality. AUC: area under the curve, CI: confidence interval,
TP: true positive, FN: false negative, TN: true negative, FP: false positive, PPV: positive predictive value, NPV: negative predictive value,
OR: odds ratio.
Statistics

Definitions

Disease

Mortality

AUC

0.817

0.752

95% CI

0.776–0.859

0.652–0.852

Best cut-off point

>2.565

>5.465

No. of cases

N

390

266

Sensitivity

TP / (TP + FN)

187/266 (70.3%)

12/16 (75.0%)

Specificity

TN / (TN + FP)

115/124 (92.7%)

169/250 (67.6%)

PPV

TP / (TP + FP)

187/196 (95.4%)

12/93 (12.9%)

NPV

TN / (TN + FN)

115/194 (59.3%)

169/173 (97.7%)

OR (95% CI)

30.246 (14.611–62.613)

6.259 (1.958–20.010)

P-value

<0.001

<0.001

The ROC curve analysis was performed to detect the best
cut-off value of NLR in the prediction of early all-cause
mortality. Serum NLR of >5.465 demonstrated a sensitivity
of 75.0% and a specificity of 67.6% for the prediction of
early all-cause mortality (AUC = 0.752; 95% CI: 0.652–
0.852; Table 2). Additionally, the positive predictive value
(PPV) and the negative predictive value (NPV) of this
ratio to predict early all-cause mortality were 12.9% and
97.7%, respectively (OR = 6.259, 95% CI: 1.958–20.010, P
< 0.001; Table 2).
According to the multiple logistic regression analysis,
NLR of >2.565 was able to define patients with PE
compared to the control group independently (OR =
35.077; 95% CI: 16.595–74.143; P < 0.001). Further

multiple logistic regression analysis showed that NLR of
>5.465 could define cases of death among patients with PE
independently (OR = 13.446, 95% CI: 3.141–57.566, P <
0.001; Table 3).
Demographic and laboratory characteristics of patients
with PE were compared between those who survived
and those who died due to PE. Although D-dimer and
troponin levels were higher in the patients that died, the
differences were not statistically significant (Table 4).
Mean WBC levels were significantly higher in the group of
patients who survived (P = 0.002). On the other hand, NLR
values were higher in the deceased group compared to the
surviving patients (OR = 1.104, 95% CI: 1.024–1.191, P <
0.001; Table 4).

Table 3. The effect of NLR on both disease and mortality after adjustment for all confounding factors.
Variables

Odds ratio

95% Confidence interval

P-value

Age

0.977

0.955–1.000

0.051

Female factor

1.594

0.922–2.756

0.095

NLR > 2.565

35.077

16.595–74.143

<0.001

Female factor

3.677

0.968–13.975

0.056

WBC

0.690

0.549–0.868

0.002

NLR > 5.465

13.446

3.141–57.566

<0.001

Case vs. controls

Surviving vs. mortal
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Table 4. Demographical and clinical characteristics regarding surviving and deceased groups.
Variables

Alive

Deceased

P-value

OR (95% CI)

Age, years

64.7 ± 14.5

66.9 ± 9.0

0.548

1.012 (0.974–1.051)

Male, n (%)

115 (46.0)

4 (25.0)

-

1.000

Female, n (%)

135 (54.0)

12 (75.0)

0.101

2.556 (0.802–8.141)

pH

7.43 (0.07)

7.42 (0.07)

0.289

0.002 (0.000–19.331)

pO2 (IQR)

56.5 (27.3)

50.9 (35.1)

0.981

1.008 (0.981–1.037)

pCO2 (IQR)

39.2 (13.8)

39.8 (16.0)

0.756

0.991 (0.955–1.028)

D-dimer, mg/L (IQR)

1.6 (1.7)

2.9 (2.3)

0.170

1.212 (0.882–1.666)

Troponin, ng/mL (IQR)

0.02 (0.08)

0.07 (0.21)

0.167

1.361 (0.805–2.301)

WBC, %

11.8 ± 2.8

9.4 ± 2.5

0.002

0.755 (0.625–0.912)

Neutrophil, %

61.1

74.6

0.001

0.755 (0.619–0.892)

Lymphocyte, %

16.5

9.2

0.003

0.275 (0.175–0.375)

NLR

3.7

9.0

<0.001

1.104 (1.024–1.191)

Sex

4. Discussion
We evaluated the relationship between NLR and the
presence and prognosis of PE detected in 266 subjects
undergoing multislice CT pulmonary angiography for
suspected PE. The findings of the present study indicated
for the first time that NLR is an independent predictor of
acute mortality in patients with PE. Our results encourage
the use of NLR as a powerful and inexpensive parameter
for the risk stratification of patients with PE.
The number of leukocytes and the ratio of their
subtypes are regarded as markers of inflammation in
cardiovascular diseases (8). NLR is an indicator of
subclinical inflammation. The meaning of elevated NLR
remains unclear; however, it causes a higher neutrophil
count compared to lymphocyte count in response to stress
such as infection and inflammation. This ratio, which
can be calculated easily, may be used as an independent
prognostic factor in PE. Previous studies have shown its
prognostic significance in heart failure and stable or acute
coronary artery disease (9–11). It has been demonstrated
that mortality increased with the increase in NLR in
patients with acute coronary syndrome and those who
underwent cardiovascular intervention (9,12). In some
studies, neutrophilia was found to be associated with
decompensated heart failure related to acute myocardial
infarction while relative lymphopenia was reported to
be an independent marker of mortality in heart failure.
Given these data, NLR is being used as a sign of prognosis
following coronary bypass grafting and during the course
of chronic heart failure (10,13).

NLR can be useful not only as a prognostic tool but
also as a diagnostic tool. The presence of T lymphocytes
in a tumor is an indicator of increased immune response
to a lesion. Recent data demonstrate that a low number of
lymphocytes in a colorectal tumor is associated with poor
prognosis. The prognostic value of NLR was investigated in
patients diagnosed with colorectal, ovary, and lung cancer
and those who underwent liver transplantation, and a
strong correlation was found with overall survival (14–19).
In the present study, a correlation was found between
NLR and mortality due to PE. We know that PE is
associated with a leukocyte influx that occurs early after
PE. Thrombus development is associated with deep
venous and pulmonary arterial wall inflammation marked
by an early extravasation of leukocytes and an elevation in
proinflammatory mediators and selectins, indicating that
a robust immune response occurred with right ventricle
damage following PE. In particular, neutrophils are the
first leukocytes to be found in the damaged pulmonary
area. Procoagulants are secreted locally by leukocytes
that contribute to oxidative and proteolytic injury
(4–6). There is also an accumulation of the monocyte/
macrophages that occurs within both the pulmonary
artery wall and the parenchyma after PE, and these cells
likely play an important role in embolism resolution.
In contrast to neutrophils, monocytes migrate from
capillaries to the extravascular space and are transformed
into macrophages and outnumber neutrophils 2–3 days
after the acute episode. Macrophage-secreted cytokines
stimulate fibroblast proliferation and collagen production
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and also promote monocytosis (20). It is well known that
right ventricular damage contributes to poor clinical
outcome after PE, and one study reported that neutrophils
contribute to right ventricular dysfunction in PE (21).
It is well known that advanced age and D-dimer levels,
although nonspecific, have prognostic value and have
high sensitivity in PE. The majority of PE patients were
reported to be between the ages of 60 and 70 years in
clinical studies and between the ages of 70 and 80 years
in autopsy series (22,23). The ratio of males to females
was reported to be approximately 1.24. The mortality
rate in males was found to be higher. Mortality difference
between males and females is more prominent after the
age of 40 years (22). In the present study, the number of
females was higher than the number of males. However,
in terms of age distribution and mortality rates, our results
were comparable with the literature. In a study by Galle et
al., the plasma D-dimer level was reported to be directly
proportional to the severity of PE (24). In most PE patients,
D-dimer levels are high, but D-dimer levels may also rise
in the presence of advanced age, inflammatory conditions,
trauma, pregnancy, infection, and malignity and in the
postoperative period. One or more of these conditions,
causing an increase in D-dimer levels, may coexist in
patients diagnosed with PE. Therefore, it is proposed that
D-dimer should be used to exclude the diagnosis of PE,
not as a marker of prognosis (25). In the present study,

a significant relationship was found between D-dimer
and the diagnosis of PE, but no significant relation was
revealed between D-dimer levels and mortality. However,
a higher NLR was associated with increased mortality in
patients with PE.
Our present study has some major limitations. First,
this is an observational, single-institution, retrospective
study, which had a relatively small sample size and was
thus subject to various unaccounted confounders inherent
in such an analysis. Additionally, we could not compare
NLR with other inflammatory markers, such as C-reactive
protein, fibrinogen, or myeloperoxidase, because they were
not routinely obtained in our study population. Long-term
outcomes of the patients discharged from hospital are
unknown. No autopsy was performed for defining purely
PE-related deaths.
In conclusion, increased NLR as a simple nonspecific
marker of inflammation is associated with increased
mortality in patients with PE. With its universal availability,
it may serve as an inexpensive new tool for risk stratification
in PE. Regardless of whether the association between NLR
and mortality reflects a fundamental pathophysiological
process or is a marker of the severity of the embolic
episode, the results of this study have important clinical
implications. Further large-scale randomized prospective
studies are required to clearly understand the exact role of
NLR in the pathophysiology of PE.
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